MarginsXMarginsX
Home › Canada › CSE stocks › MRMD

MariMed Inc. (CSE: MRMD)

MRMD trades on the Canadian Securities Exchange in Life Sciences. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.

Close · November 13, 2026
C$0.0950
-9.52% on the day
Market cap (C$)
C$38.6M
TMX list, November 16, 2026
Market cap (US$)
US$27.1M
Nano cap at 1.4257 C$/US$
1-year return
-26.9%
-20.8% year to date

Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of November 16, 2026. US$ figures convert C$ at 1.4257 C$ per US$, the Bank of Canada daily rate for November 13, 2026. Close and returns: Yahoo Finance daily closes for MRMD.CN, last bar 2026-11-13, computed by MarginsX. Website: sociallinks: 10-K text ("our website").

Profile

FieldValue
TickerMRMD on the Canadian Securities Exchange
Yahoo symbolMRMD.CN
SectorLife Sciences, Drug Manufacturers—Specialty & Generic
HeadquartersThe TMX list gives no head office
ListedThe TMX list gives no listing date
Listing typeTMX leaves listing type blank for long-listed issuers
Shares outstanding405,996,010
Also listed onNo interlisting on the TMX list
Index membershipNot in an S&P/TSX index per the TMX list
SEC CIK0001522767
Websitewww.marimedinc.com

Returns

WindowReturn
1 day-9.5%
1 week0.0%
1 month+11.8%
3 months0.0%
6 months-13.6%
Year to date-20.8%
1 year-26.9%
From 52-week high-48.6%
52-week rangeC$0.0650 to C$0.1850

Links

SEDAR+ is linked for searching only; nothing on this page is taken from it.

Recent Canadian filings by type

27 documents in 7 types. Each title links to the document at its source.

News release (4)

Management information circular / proxy (1)

DocumentTypeFiled
DEF 14AProxy statement (DEF 14A)2026-09-22

Annual report (4)

DocumentTypeFiled
Form ARS: Annual report to security holdersAnnual report to shareholdersNo date
Form ARS: Annual Report to Security HoldersAnnual report to shareholdersNo date
Form ARS: Annual Report to Security HoldersAnnual report to shareholdersNo date
Form ARS: Annual report to security holdersAnnual report to shareholdersNo date

Quarterly report (1)

DocumentTypeFiled
10-Q
Period 2026-09-30
Quarterly report (10-Q) (10-Q)2026-11-13

Insider report (8)

DocumentTypeFiled
Form 4Form 4 (4)2026-11-09
Form 4Form 4 (4)2026-10-15
Form 4Form 4 (4)2026-10-15
Form 4Form 4 (4)2026-10-15

Certification (4)

DocumentTypeFiled
EX-31.1
Period 2026-09-30
Certification (SOX 302/906) (10-Q)2026-11-13
EX-31.2
Period 2026-09-30
Certification (SOX 302/906) (10-Q)2026-11-13
EX-32.1
Period 2026-09-30
Certification (SOX 302/906) (10-Q)2026-11-13
EX-32.2
Period 2026-09-30
Certification (SOX 302/906) (10-Q)2026-11-13

Other (5)

DocumentTypeFiled
8-KCurrent report (8-K) (8-K)2026-11-12
8-KCurrent report (8-K) (8-K)2026-10-29
8-KCurrent report (8-K) (8-K)2026-09-23
MariMed Investor Presentation View PresentationInvestor presentationNo date

Sources: SEC EDGAR filings (public records); Company investor-relations website (links only, documents not copied). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.

Trading halts

No CIRO halt notices for this company in our data.

Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.

Upcoming events

No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.

Recent

DateTimeEventWebcastSource
2026-11-12No time in the announcementQ3 2026 earnings releaseNo webcast link announcedSEC filing
2026-11-128:00 a.m. Eastern timeQ3 2026 earnings callWebcastSEC filing
2026-10-28No time in the announcementSpecial meeting
Shareholder meeting
No webcast link announcedSEC filing

Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.

Peers in Life Sciences

TickerCompanyExchangeMarket cap (C$)1 month1 year
MIRMedMira Inc.TSXVC$37.9M-42.9%-42.9%
BCTBriaCell Therapeutics Corp.TSXC$37.5M-7.9%-64.4%
SVASernova Biotherapeutics Inc.TSXC$39.7M0.0%-21.4%
LSLLSL Pharma Group Inc.TSXVC$39.9M+8.3%-7.1%
PLTHPlanet 13 Holdings Inc.CSEC$40.2M-20.0%-50.0%

The app has the price chart, every filing, private raises and the full peer set for MRMD.

Open in the app